Skip to main content
. Author manuscript; available in PMC: 2024 Apr 25.
Published in final edited form as: JACC Heart Fail. 2023 Feb;11(2):211–223. doi: 10.1016/j.jchf.2022.11.007

Central Illustration. Applicability of Vericiguat to US Patients Hospitalized for HF with EF<45%.

Central Illustration.

Clinical characteristics, clinical outcomes, and clinical outcomes among VICTORIA eligible patients, FDA label patients, the hospitalized HF with EF <45% population in GWTG-HF, as well as patients enrolled in the VICTORIA randomized trial. ARNI=Angiotensin receptor neprilysin inhibitor; ARB= Angiotensin receptor blocker; ACEI= Angiotensin converting enzyme inhibitor.